Abstract PS4-03-10: Assessing the impact of real-time serial circulating tumor cell results on the management of patients with metastatic breast cancer

Clinical Cancer Research 2026

View at publisher
Authors: K. V. Giridhar, David M. Zahrieh, Mina Samir Erian Hanna, A. Singh, Eyad Al‐Hattab, P. Schumacher, J. Carroll, Jenna Elizabeth Hoppenworth, TC Haddad, Amye J. Tevaarwerk, B. Rudder, G. M. Choong
+11 more S. Basu, Roberto Antonio Leon-Ferre, T. O'Brien, A. Lewis, Femke De Snoo, Lisette Stork‐Sloots, F. K. Kuhr, S. Lazaro, R. Prendergast, Daryl S. Spinner, Matthew Philip Goetz
DOI: 10.1158/1557-3265.sabcs25-ps4-03-10
Cited by: 0

Abstract

Abstract Introduction Serial assessments of circulating tumor cells (CTCs) in metastatic breast cancer (MBC) provide independent prognostic significance for progression free survival and overall survival. A low CTC burden (

Fields of Study & Subjects

Cancer Genomics and Diagnostics Breast Cancer Treatment Studies Cancer Cells and Metastasis

Publication details

Journal / source
Clinical Cancer Research
Volume
32
Issue
4_Supplement
Pages
PS4–03
Publication date
17 February 2026
Language
EN